Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling

The lack of robust Parkinson's disease (PD) phenotype in parkin knockout rodents and the identification of defective dopaminergic (DA) neurotransmission in midbrain DA neurons derived from induced pluripotent stem cells (iPSC) of PD patients with parkin mutations demonstrate the utility of patient-specific iPSCs as an effective system to model the unique vulnerabilities of midbrain DA neurons in PD. Significant efforts have been directed at developing efficient genomic engineering technologies in human iPSCs to study diseases such as PD. In the present study, we converted patient-specific iPSCs from the primed state to a naivetropic state by DOX-induced expression of transgenes (Oct4, Sox2, Klf4, c-Myc, and Nanog) and the use of 2iL (MEK inhibitor PD0325901, GSK3 inhibitor CHIR99021, and human LIF). These patient-specific naivetropic iPSCs were pluripotent in terms of marker expression, spontaneous differentiation in vitro, and teratoma formation in vivo. They exhibited morphological, proliferative, and clonogenic characteristics very similar to naive mouse embryonic stem cells (ESC). The high clonal efficiency and proliferation rate of naivetropic iPSCs enabled very efficient gene targeting of GFP to the PITX3 locus by transcription activator-like effector nuclease. The naivetropic iPSCs could be readily reverted to the primed state upon the withdrawal of DOX, 2iL, and the switch to primed-state hESC culture conditions. Midbrain DA neurons differentiated from the reverted iPSCs retained the original phenotypes caused by parkin mutations, attesting to the robustness of these phenotypes and the usefulness of genomic engineering in patient-specific naivetropic iPSCs for studying PD.

[1]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  F. Campos Rat models of Parkinson's disease: insights into the treatment of refractory symptoms , 2015 .

[3]  Graziano Martello,et al.  The nature of embryonic stem cells. , 2014, Annual review of cell and developmental biology.

[4]  Kuldip D. Dave,et al.  Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease , 2014, Neurobiology of Disease.

[5]  J. Nichols,et al.  Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human , 2014, Cell.

[6]  Kun Zhang,et al.  Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. , 2014, Cell stem cell.

[7]  Chad A. Cowan,et al.  Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. , 2014, Cell stem cell.

[8]  Feng Chen,et al.  Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones. , 2014, Cell stem cell.

[9]  R. Young,et al.  Systematic Identification of Culture Conditions for Induction and Maintenance of Naive Human Pluripotency , 2014, Cell stem cell.

[10]  Angelique M. Nelson,et al.  Derivation of naïve human embryonic stem cells , 2014, Proceedings of the National Academy of Sciences.

[11]  H. Ng,et al.  Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. , 2013, Cell stem cell.

[12]  I. Amit,et al.  Derivation of novel human ground state naive pluripotent stem cells , 2013, Nature.

[13]  Patrick J. Paddison,et al.  Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3 , 2013, Cell.

[14]  J. Paul Bolam,et al.  The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease , 2013, Front. Comput. Neurosci..

[15]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[16]  Jian Feng,et al.  Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells , 2012, Current Neurology and Neuroscience Reports.

[17]  C. Ware,et al.  HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC‐to‐EpiSC/hESC transition , 2012, The EMBO journal.

[18]  Zhen Yan,et al.  Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells , 2012, Nature Communications.

[19]  Roland Rad,et al.  Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1 , 2011, Proceedings of the National Academy of Sciences.

[20]  Erin L. Doyle,et al.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.

[21]  J. Hardy,et al.  Genetic Analysis of Pathways to Parkinson Disease , 2010, Neuron.

[22]  E. Rebar,et al.  Genome editing with engineered zinc finger nucleases , 2010, Nature Reviews Genetics.

[23]  Ted M. Dawson,et al.  Genetic Animal Models of Parkinson's Disease , 2010, Neuron.

[24]  Hsu-hsin Chen,et al.  A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. , 2010, Cell stem cell.

[25]  C. Lengner,et al.  Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs , 2010, Proceedings of the National Academy of Sciences.

[26]  M. Raff New Routes into the Human Brain , 2009, Cell.

[27]  J. Nichols,et al.  Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo , 2009, Development.

[28]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.

[29]  Ge Guo,et al.  Nanog Is the Gateway to the Pluripotent Ground State , 2009, Cell.

[30]  J. Nichols,et al.  Validated germline-competent embryonic stem cell lines from nonobese diabetic mice , 2009, Nature Medicine.

[31]  F. Fujiyama,et al.  Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum , 2009, The Journal of Neuroscience.

[32]  Sheng Ding,et al.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. , 2009, Cell stem cell.

[33]  B. Doble,et al.  The ground state of embryonic stem cell self-renewal , 2008, Nature.

[34]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[35]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[36]  T. Graf Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[37]  R. McKay,et al.  New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.

[38]  M. Trotter,et al.  Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.

[39]  S. Nishikawa,et al.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells , 2007, Nature Biotechnology.

[40]  Wenhua Liu,et al.  Parkin Suppresses the Expression of Monoamine Oxidases* , 2006, Journal of Biological Chemistry.

[41]  R. Palmiter,et al.  Parkin-deficient mice are not a robust model of parkinsonism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Robert E. Burke,et al.  Pitx3 is required for development of substantia nigra dopaminergic neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[44]  G Wolterink,et al.  A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  O. Hornykiewicz Pharmacology and pathophysiology of dopaminergic neurons. , 1971, Advances in cytopharmacology.

[46]  A. Carlsson,et al.  The occurrence, distribution and physiological role of catecholamines in the nervous system. , 1959, Pharmacological reviews.

[47]  J. Shih,et al.  Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.